Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case
Articolo
Data di Pubblicazione:
2016
Citazione:
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case / L. Siragusa, R. Luciani, C. Borsari, S. Ferrari, M.P. Costi, G. Cruciani, F. Spyrakis. - In: CHEMMEDCHEM. - ISSN 1860-7179. - 11:15(2016 Aug 05), pp. 1653-1666. [10.1002/cmdc.201600121]
Abstract:
Repurposing and repositioning drugs has become a frequently pursued and successful strategy in the current era, as new chemical entities are increasingly difficult to find and get approved. Herein we report an integrated BioGPS/FLAPdock pipeline for rapid and effective off-target identification and drug repurposing. Our method is based on the structural and chemical properties of protein binding sites, that is, the ligand image, encoded in the GRID molecular interaction fields (MIFs). Protein similarity is disclosed through the BioGPS algorithm by measuring the pockets’ overlap according to which pockets are clustered. Co-crystallized and known ligands can be cross-docked among similar targets, selected for subsequent in vitro binding experiments, and possibly improved for inhibitory potency. We used human thymidylate synthase (TS) as a test case and searched the entire RCSB Protein Data Bank (PDB) for similar target pockets. We chose casein kinase IIα as a control and tested a series of its inhibitors against the TS template. Ellagic acid and apigenin were identified as TS inhibitors, and various flavonoids were selected and synthesized in a second-round selection. The compounds were demonstrated to be active in the low-micromolar range.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
cross docking; drug discovery; drug repurposing; thymidylate synthase; virtual screening;
Elenco autori:
L. Siragusa, R. Luciani, C. Borsari, S. Ferrari, M.P. Costi, G. Cruciani, F. Spyrakis
Link alla scheda completa: